We are live on ! Find out more
DB

Dmitry Balyasny Balyasny Asset Management

AUM $80.2B
1-Year Est. Return 51.53%
 

Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.

This Fund
S&P 500
This Quarter Est. Return
+1.22%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.37%
10 Year Est. Return
+1,172.21%
AUM
$57.1B
AUM Growth
-$109M
Cap. Flow
-$507M
Cap. Flow %
-0.89%
Top 10 Hldgs %
13.27%
Holding
3,274
New
730
Increased
855
Reduced
816
Closed
774

Sector Composition

Rank Sector Weight
1 Industrials 9.54%
2 Consumer Discretionary 9.3%
3 Financials 8.79%
4 Technology 8.62%
5 Healthcare 6.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOUG icon
2426
Douglas Elliman
DOUG
$177M
$29.2K ﹤0.01%
+25,184
New +$31.7K
NOTV
2427
DELISTED
Inotiv
NOTV
$27.7K ﹤0.01%
16,681
-53,530
-76% -$197K
DHX icon
2428
DHI Group
DHX
$183M
$27.2K ﹤0.01%
+12,994
New +$30.1K
NVX
2429
NOVONIX
NVX
$105M
$26.9K ﹤0.01%
+15,000
New +$33.5K
HOWL icon
2430
Werewolf Therapeutics
HOWL
$42.9M
$25.5K ﹤0.01%
10,459
-12,589
-55% -$60.5K
TLRY icon
2431
Tilray
TLRY
$649M
$25K ﹤0.01%
1,503
-133
-8% -$2.55K
ASRT
2432
DELISTED
Assertio
ASRT
$24.9K ﹤0.01%
+1,336
New +$19.9K
XAGEW
2433
DELISTED
Longevity Health Holdings, Inc. Warrant
XAGEW
$24.8K ﹤0.01%
342,706
BW icon
2434
Babcock & Wilcox
BW
$1.15B
$24.6K ﹤0.01%
+16,951
New +$20.4K
KOD icon
2435
Kodiak Sciences
KOD
$2.34B
$23.6K ﹤0.01%
+10,037
New +$34K
GEVO icon
2436
Gevo
GEVO
$378M
$23.3K ﹤0.01%
41,891
-8,341
-17% -$5.59K
AMWL icon
2437
American Well
AMWL
$203M
$22.7K ﹤0.01%
+3,501
New +$35.2K
ORGN
2438
DELISTED
Origin Materials
ORGN
$21K ﹤0.01%
+776
New +$20.7K
GWH icon
2439
ESS Tech
GWH
$12.8M
$20.7K ﹤0.01%
1,689
+375
+29% +$4.22K
FEAM icon
2440
5E Advanced Materials
FEAM
$68.9M
$20.6K ﹤0.01%
+741
New +$23.2K
PL icon
2441
Planet Labs
PL
$7.69B
$20.6K ﹤0.01%
+11,065
New +$21.2K
EOSE icon
2442
Eos Energy Enterprises
EOSE
$1.26B
$20.5K ﹤0.01%
+16,166
New +$13.4K
SEER icon
2443
Seer Inc
SEER
$113M
$19.8K ﹤0.01%
+11,806
New +$22K
KPTI icon
2444
Karyopharm Therapeutics
KPTI
$42.2M
$19.6K ﹤0.01%
+1,504
New +$24.9K
MVST icon
2445
Microvast
MVST
$298M
$19K ﹤0.01%
+41,725
New +$18.7K
NDLS icon
2446
Noodles & Co
NDLS
$93.6M
$18.7K ﹤0.01%
+1,483
New +$21.1K
MAXN
2447
DELISTED
Maxeon Solar Technologies
MAXN
$17.9K ﹤0.01%
+210
New +$44.5K
KYNB
2448
Kyntra Bio
KYNB
$32.3M
$17.3K ﹤0.01%
+776
New +$24K
EXFY icon
2449
Expensify
EXFY
$248M
$16.9K ﹤0.01%
+11,325
New +$17.9K
FOSL icon
2450
Fossil Group
FOSL
$329M
$16.1K ﹤0.01%
+11,162
New +$12.7K

Similar funds

Dmitry Balyasny's Q2 2024 Portfolio in Review

As of Q2 2024, Dmitry Balyasny held 3,274 positions worth $57.1B, down 0.19% from $57.2B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Dmitry Balyasny's Q2 2024 filing shows 730 new, 855 increased, 816 reduced and 774 closed positions. Its largest new stake was Intercontinental Exchange: 1,498,857 shares worth $205M. The largest sale was Pioneer Natural Resource Co., an estimated $777M.

By sector, the portfolio is most concentrated in Industrials at 9.5% of assets, up from 8.1% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Dmitry Balyasny's largest Q2 2024 buy was Intercontinental Exchange: 1,498,857 shares worth $205M.
  • Dmitry Balyasny added most to Apple in Q2 2024, an estimated $444M increase.
  • Dmitry Balyasny's biggest Q2 2024 reduction was Meta Platforms (Facebook), cutting an estimated $317M.
  • Dmitry Balyasny fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $777M.
  • Dmitry Balyasny's ten largest holdings make up 13% of its $57.1B portfolio in Q2 2024.
  • Dmitry Balyasny opened 730 new positions and closed 774 in Q2 2024.
  • Dmitry Balyasny's portfolio value fell 0.19% quarter-over-quarter to $57.1B.

Based on Balyasny Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.